|

A Multicenter Pediatric Deep Brain Stimulation Registry

RECRUITINGSponsored by Boston Children's Hospital
Actively Recruiting
SponsorBoston Children's Hospital
Started2024-07-30
Est. completion2029-07-30
Eligibility
Age0 Years – 18 Years
Healthy vol.Accepted
Locations1 site

Summary

There is limited data on outcomes for children who have undergone deep brain stimulation (DBS) for movement disorders, and individual centers performing this surgery often lack sufficient cases to power research studies adequately. This study aims to develop a multicenter pediatric DBS registry that allows multiple sites to share clinical pediatric DBS data. The primary goals are to enable large-scale, well-powered analyses of the safety and efficacy of DBS in the pediatric population and to further explore and refine DBS as a therapeutic option for children with dystonia and other hyperkinetic movement disorders. Given the current scarcity of evidence available to clinicians, this centralized multicenter repository of clinical data is critical for addressing key research questions and improving clinical practice for pediatric DBS.

Eligibility

Age: 0 Years – 18 YearsHealthy volunteers accepted
Inclusion Criteria:

* Female or male patients between ages of 0-18 years.
* Having received or scheduled to receive DBS for any neurological movement disorder.
* Parents or legal guardians are able to provide written consent for prospective enrollment.

Conditions10

AnxietyCerebral PalsyDeep Brain StimulationDystoniaEpilepsy in ChildrenMovement DisordersMovement Disorders in ChildrenNeurologic DisorderObsessive-compulsive DisorderTourette Syndrome

Locations1 site

Boston Children's Hospital
Boston, Massachusetts, 02215
Darius Ebrahimi-Fakhari, MD, PhD.617-355-0097movementdisorders@children.harvard.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.